A Controlled Comparison of Diazepam and Amylobarbitone in Anxiety States
- 1 June 1966
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 112 (487) , 629-631
- https://doi.org/10.1192/bjp.112.487.629
Abstract
Amylobarbitone has been shown to be effective in the symptomatic treatment of neurotic anxiety in a number of controlled trials (Raymond et al, 1957; Scott, 1955; Robin, 1959), and can therefore be used as a standard of comparison in the treatment of anxiety states. It is here compared with diazepam (7-chloro-1,3-dihydro-1 -methyl-5-phenyl-2H-1,4-benzodiazepin-2-one).Keywords
This publication has 9 references indexed in Scilit:
- A Validation Study of NealbarbitoneThe British Journal of Psychiatry, 1964
- Diazepam, Meprobamate, and Placebo in Musculoskeletal DisordersJAMA, 1964
- COMPARATIVE CHEMOTHERAPEUTIC TRIAL IN TREATMENT OF CHRONIC BORDERLINE PATIENTSAmerican Journal of Psychiatry, 1964
- A CONTROLLED STUDY OF DIAZEPAM IN PSYCHIATRIC OUTPATIENTSAmerican Journal of Psychiatry, 1964
- Comparison of Diazepam, Chlorpromazine and A Placebo in Psychiatric PracticeThe Journal of New Drugs, 1963
- A double blind crossover comparison of Diazepam (Valium, Ro 5?2807) with chlordiazepoxide (Librium) in the treatment of neurotic anxietyPsychopharmacology, 1962
- Pecazine (“Pacatal”) Compared with Amylobarbitone Sodium in Anxiety StatesJournal of Mental Science, 1959
- A Trial of Five Tranquillizing Drugs in PsychoneurosisBMJ, 1957
- A Controlled Study of the Effect of Mephenesin on Psychiatric Out-PatientsJournal of Mental Science, 1955